BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus
Fabien B. Vincent(Monash Medical Centre), Fabienne Mackay(QIMR Berghofer Medical Research Institute)
Cited by 88
Related Papers
Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7
|Proceedings of the National Academy of Sciences|2007|622
The BAFF/APRIL system in SLE pathogenesis
|Nature Reviews Rheumatology|2014|441
Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55.
|The Journal of Experimental Medicine|1993|392
Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
|Annals of the Rheumatic Diseases|2012|349
NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells
|Proceedings of the National Academy of Sciences|2008|103